Cargando…
Targeting heart failure with preserved ejection fraction: current status and future prospects
Heart failure with preserved ejection fraction (HFpEF) portrays a significant burden in terms of prevalence, morbidity, mortality, and health care costs. There is a lack of consensus on the basic pathophysiology, definition, and therapeutic targets for therapy for this syndrome. To date, there are n...
Autores principales: | Kanwar, Manreet, Walter, Claire, Clarke, Megan, Patarroyo-Aponte, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841115/ https://www.ncbi.nlm.nih.gov/pubmed/27143907 http://dx.doi.org/10.2147/VHRM.S83662 |
Ejemplares similares
-
Heart failure with preserved ejection fraction: current status and challenges for the future
por: van der Velden, J., et al.
Publicado: (2016) -
Heart failure with preserved ejection fraction: present status and future directions
por: Yoon, Somy, et al.
Publicado: (2019) -
Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations
por: Kassis-George, Hayah, et al.
Publicado: (2022) -
Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
por: Kessler, Elise L., et al.
Publicado: (2020) -
Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
por: Rosch, Sebastian, et al.
Publicado: (2020)